Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

A new method accurately measures nine specific hormones in human blood.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Dutasteride and finasteride affect different cell types differently.

Minoxidil can reduce functions related to androgen receptors.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Certain drugs that block specific enzymes can help treat prostate diseases.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.